Recent Mendelian randomization studies linking AD to reduced CRC risk via TET2-mediated immune and epigenetic regulation were based largely on Western datasets, and their generalizability to East Asian populations remains uncertain [23]. This evidence concerns the gene TET2 and colorectal carcinoma.